Phenotypic study of resistance of β-lactamase-inhibitor-resistant TEM enzymes which differ by naturally occurring variations and by site-directed substitution at Asp276

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 6, 1998, Pages 1323-1328

  Caniça, M Manuela ^a,b,c,e   Caroff, Nathalie ^a,f   Barthélémy, Michel ^b   Labia, Roger ^d   Krishnamoorthy, Rajagopal ^c   Paul, Gérard ^a,g   Dupret, Jean Marie ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d UMR 175   (France)

^e National Health Institute Doutor Ricardo Jorge   (Portugal)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g UFR de Medecine Cochin Port Royal ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; BETA LACTAMASE TEM 1; CEFALORIDINE; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; IMIPENEM; MECILLINAM; MEZLOCILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TICARCILLIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM MUTANT; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0031805291     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.6.1323     Document Type: Article

References (42)

1. Ambler, R. P., A. F. W. Coulson, J.-M. Frère, J.-M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme tor the class A β-lactamases. Biochem. J. 276:269-272.
2. Belaaouaj, A., C. Lapoumeroulie, M. M. Caniça, G. Vedel, P. Névot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75-80.
3. Blazquez, J., M.-R. Baquero, R. Canton, I. Alos, and F. Baquero. 1993. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:2059-2063.
4. Bonomo, R. A., C. G. Dawes, J. R. Knox, and D. M. Shlaes. 1995. β-Lactamase mutations far from the active site influence inhibitor binding. Biochim. Biophys. Acta 1247:121-125.
5. Bret, L., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1996. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains. J. Antimicrob. Chemother. 38:183-191.
6. Brown, R. P. A., R. T. Aplin, and C. J. Schofield. 1996. Inhibition of TEM-2 β-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry. Biochemistry 35: 12421-12432.
7. Brun, T., J. Péduzzi, M. M. Caniça, G. Paul, P. Névot, M. Barthélémy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to β-lactamase inhibitors. FEMS Microbiol. Lett. 120:111-118.
8. Bullock, W. O., J. M. Fernandez, and J. M. Short. 1987. XL1-Blue: a high efficiency plasmid transforming recA Escherichia coli strain with beta-galactosidase selection. Bio Techniques 5:376-378.
9. Bush, K., and R. B. Sykes. 1986. Methodology for the study of β-lactamases. Antimicrob. Agents Chemother. 30:6-10.
10. Caniça, M. M., M. Barthélémy, L. Gilly, R. Labia, R. Krishnamoorthy, and G. Paul. 1997. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type β-lactamases. Antimicrob. Agents Chemother. 41:374-378.
11. Caniça, M. M., C. Deloménie, R. Labia, R. Krishnamoorthy, and G. Paul. 1996. Characterization of the mutant produced by site-directed mutagenesis generating the substitution Asn-276→-Asp in the critical proximity of Arg244 in TEM-1 β-lactamase, abstr. 24/C3, p. 100. In Program and abstracts of the 16th Interdisciplinary Meeting on Anti-Infectious Chemotherapy.
12. TEM genes encoding β-lactamases resistant to clavulanic acid in clinical E. coli. J. Mol. Evol. 44:57-65.
13. TEM gene using an artificially created restriction site, abstr. 360/P24, p. 228. In Program and abstracts of the 15th Interdisciplinary Meeting on Anti-Infectious Chemotherapy.
14. Chen, C. C. H., and O. Herzberg. 1992. Inhibition of β-lactamase by clavulanate. Trapped intermediates in cryocrystallographic studies. J. Mol. Biol. 224:1103-1113.
15. Cohen, S. N., A. C. Y. Chang, and L. Hsu. 1972. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc. Natl. Acad. Sci. USA 69:2110-2114.
16. Delaire, M., R. Labia, J.-P. Samama, and J.-M. Masson. 1992. Site-directed mutagenesis at the active site of Escherichia coli TEM-1 β-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis. J. Biol. Chem. 267:20600-20606.
17. Du Bois, S. K., M. S. Marriott, and S. G. B. Amyes. 1995. TEM- and SHV-derived extended-spectrum β-lactamases: relationship between selection, structure and function. J. Antimicrob. Chemother. 35:7-22.
18. Fonzé, E., P. Charlier, Y. Toth, M. Vermeire, X. Raquet, A. Dubus, and J.-M. Frère. 1995. TEM-1 β-lactamase structure solved by molecular replacement and refined structure of the S235A mutant. Acta Crystallogr. 51:682-694.
19. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
20. Herzberg, O. 1991. Refined crystal structure of β-lactamase from Staphylococcus aureus PC1 at 2.0 Å resolution. J. Mol. Biol. 217:701-719.
21. Imtiaz, U., E. Billings, J. R. Knox, E. K. Manavathu, S. A. Lerner, and S. Mobashery. 1993. Inactivation of class A β-lactamases by clavulanic acid: the role of arginine-244 in a proposed nonconcerted sequence of events. J. Am. Chem. Soc. 115:4435-4442.
22. Imtiaz, U., E. M. Billings, J. R. Knox, and S. Mobashery. 1994. A structure-based analysis of the inhibition of class A β-lactamases by sulbactam. Biochemistry 33:5728-5738.
23. Jelsch, C., L. Mourey, J.-M. Masson, and J.-P. Samama. 1993. Crystal structure of Escherichia coli TEM-1 β-lactamase at 1.8 Å resolution. Proteins Struct. Funct. Genet. 16:364-383.
24. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Antimicrob. Agents Chemother. 39:2593-2601.
25. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
26. Labia, R., J. Andrillon, and F. Le Goffic. 1973. Computerized microacidimetric determination of β-lactamase Michaelis-Menten constants. FEBS Lett. 33:42-44.
27. Labia, R., M. Barthélémy, C. Fahre, M. Guionie, and J. Péduzzi. 1979. Kinetic studies of three R-factor mediated β-lactamases, p. 429-442. In J. M. T. Hamilton-Miller and J. T. Smith (ed.), Beta-lactamases. Academic Press, London, United Kingdom.
28. Labia, R., V. Lelievre, and J. Peduzzi. 1980. Inhibition kinetics of three R-factor-mediated β-lactamases by a new β-lactam sulfone (CP 45899). Biochim. Biophys. Acta 611:351-357.
29. Lenfant, F., A. Petit, R. Labia, L. Maveyraud, J.-P. Samana, and J.-M. Masson. 1993. Site-directed mutagenesis of β-lactamase TEM-1. Investigating the potential role of specific residues on the activity of Pseudomonas-specific enzymes. Eur. J. Biochem. 217:939-946.
30. Martinez, J. L., M. F. Vicente, A. Delgado-Iribarren, J. C. Perez-Diaz, and F. Baquero. 1989. Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob. Agents Chemother. 33:595. (Letter.)
31. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
32. Matthew, M., and R. W. Hedges. 1976. Analytical isoelectric focusing of R factor-determined β-lactamases: correlation with plasmid compatibility. J. Bacteriol. 125:713-718.
33. Petit, A., E. Jullian, and R. Labia. 1991. Substitution du tryptophane-165 par une arginine dans la beta-lactamase TEM-1. C. R. Acad. Sci. Paris 312: 993-997.
34. Reynaud, A., J. Péduzzi, M. Barthélémy, and R. Labia. 1991. Cefotaxime-hydrolysing activity of the β-lactamase of Klebsiella oxytoca D488 could be related to a threonine residue at position 140. FEMS Microbiol. Lett. 81: 185-192.
35. Russel, M., S. Kidd, and M. R. Kelley. 1986. An improved filamentous helper phage for generating single-stranded plasmid DNA. Gene 45:333-338.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
37. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
38. Saves, I., O. Burlet-Schiltz, P. Swarén, F. Lefèvre, J.-M. Masson, J.-C. Promé, and J.-P. Samama. 1995. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the β-lactamase resistance to clavulanic acid. J. Biol. Chem. 270:18240-18245.
39. Stapleton, P., P.-J. Wu, A. King, K. Shannon, G. French, and I. Phillips. 1995. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
40. Vedel, G., A. Belaaouaj, L. Gilly, R. Labia, A. Philippon, P. Névot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. J. Antimicrob. Chemother. 30:449-462.
41. Weiner, S. J., P. A. Kollman, D. A. Case, U. C. Singh, C. Ghio, G. Alagona, S. J. Profeta, and P. Weiner. 1984. A new force field for molecular mechanical simulation of nucleic acids and proteins. J. Am. Chem. Soc. 106:764-784.
42. Zhou, X. Y., F. Bordon, D. Sirot, M.-D. Kitzis, and L. Gutmann. 1994. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resistance to β-lactamase inhibitors. Antimicrob. Agents Chemother. 38:1085-1089.